Hahn Steve News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Coronavirus: US Deaths Pass 300,000 Amid 1st Vaccinations and Talks on Relief Package Posted by Scott Lucas | Dec 15, 2020 | Sandra Lindsay, a nurse at Long Island Jewish Medical Center, is given a Coronavirus vaccination by Dr. Michelle Chester, Queens, New York, December 14, 2020 (Mark Lennihan) UPDATE, DEC 16: The daily toll is the second-highest in the pandemic, after 3,343 last Friday. Confirmed cases are 16,717,104, with 197,512 yesterday. Hospitalizations rose to a record 112,816. After weeks of stalemate, there appeared to be some movement in Congressional talks for a stimulus packag...

FDA Chief Contradicts Trump on Vaccine Approval Timeline, Hopes 1st Shot Administered on Monday Newsweek 12/13/2020 Emily Czachor © Morry Gash/Pool/Getty Images Stephen Hahn, commissioner at the U.S. Food and Drug Administration, said he is hopeful the first COVID-19 vaccines will be administered as early as Monday. Boxes containing the Pfizer-BioNTech COVID-19 vaccine are prepared to be shipped at the Pfizer Global Supply Kalamazoo manufacturing plant on December 13, 2020 in Portage, Michigan. Stephen Hahn, commissioner at the U.S. Food and Drug Administration (FDA), con...

Print this article President Trump said the United States wouldn't have a vaccine for five years if not for his presidency. "If I wasn't president, according to almost everybody, even the enemy, if I wasn't president, you wouldn't have a vaccine for five years," Trump told Fox News's Brian Kilmeade in an interview at West Point. "I push the FDA and companies, and everybody else involved like nobody's ever been pushed before." "They call it a medical miracle, and it's going to have a tremendous impact," Trump said. The Food and Drug Administration granted an emergency use authorization for ...

FDA Grants Pfizer, BioNTech Emergency Use Authorization for COVID-19 Vaccine December 11, 2020 Pfizer and BioNTech will be the first developers of a COVID-19 vaccine to dose patients beyond clinical trials in the United States, as the FDA on Friday evening granted the companies an emergency use authorization (EUA) for their messenger RNA (mRNA)-based BNT162b2. The companies plan next week to begin distributing the first vials of BNT162b2, a two-dose vaccine that is indicated for the prevention of COVID-19 in individuals 16 years of age and older. “As a U.S. company, today’s news brings g...

 | Updated December 14, 2020 White House chief of staff Mark Meadows reportedly put pressure on Food and Drug Administration head Stephen Hahn to expedite the approval of Pfizer’s coronavirus vaccine — or risk losing his job. Meadows told Hahn on Friday to resign if the vaccine was not authorized by the end of the day, The Washington Post reported, citing people familiar with the conversation. Axios corroborated the Post’s account, saying Meadows suggested to Hahn in a Friday phone call that the FDA commissioner’s job may be at stake over the vaccine. Hahn disputed this characterizat...